Publications

TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo

 82
TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo

Tags:

Previous Article

AI discovers variation in local brain aging and cognition across human adulthood

Next Article

Immune ‘off switch’ in cancer cells discovered!

Related Posts

Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors

Cycling alpha cells in regenerative drug-treated human ...

 117

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design

Native-like soluble E1E2 glycoprotein heterodimers on s...

 61

Promoting intestinal regeneration without tumor risk in immune-mediated inflammatory diseases

Promoting intestinal regeneration without tumor risk in...

 72